Financials
Financial year 2025
CLAREXIS & CO from Vorst, company number BE1002062656, closed financial year 2025 with a result of € 296,155 after tax. For that financial year CLAREXIS & CO recorded a gross margin of € 418,842 and equity of € 919,954. Compared with financial year 2024, the result moved from € 616,299 to € 296,155. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 919,954
▲ 47% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 296,155
▼ 52% vs 2024
Profit after tax over the fiscal year.
€ 24,385
▼ 78% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 912,454.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 694,268
▼ 15% vs 2024
€ 37,508 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 1,873
▼ 56% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,537
▼ 18% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 842,114 | € 418,842 | ▼ 50% |
| Profit after taxes | € 616,299 | € 296,155 | ▼ 52% |
| Equity | € 623,799 | € 919,954 | ▲ 47% |
| Total debts | € 883,922 | € 741,245 | ▼ 16% |
| Cash | € 113,039 | € 24,385 | ▼ 78% |
| Land & buildings | - | € 14,691 | |
| Retained profit | € 616,299 | € 912,454 | ▲ 48% |
| Bank debt | € 814,311 | € 694,268 | ▼ 15% |
| Balance sheet total | € 1,507,721 | € 1,661,199 | ▲ 10% |
Key figures of CLAREXIS & CO, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CLAREXIS & CO?
What happened at CLAREXIS & CO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 296,155 (▼ 52% vs 2024). filed late Source: NBB ↗
- Noémie Keyen became a director. NBB
- New establishment in Vorst. KBO
- MARIA BARAZZUTTI became a director. NBB
- Alexis Davoine became a director. NBB
- JEAN-CHRISTOPHE DAVOINE became a director. NBB
- Clara Davoine became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 616,299 profit in 2024 to € 296,155 profit in 2025.
Paid € 290,818 in corporate taxes since 2024.
Best year ever: 2024, with € 616,299 profit.
Management
Behind CLAREXIS & CO are MARIA BARAZZUTTI, Alexis Davoine, JEAN-CHRISTOPHE DAVOINE, Noémie Keyen and Clara Davoine. It owns 100% of Pharmacie Dufrane itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Kastanjestraat 21 box 2
1190 Vorst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1002.062.656
- VAT number
- BE 1002.062.656
- Registered office
- Kastanjestraat 21 bus 2, 1190 Vorst
- Names & denominations
- CLAREXIS & CO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 November 2023
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Activiteiten van hoofdkantoren
Overige zakelijke dienstverlening, neg
Handel in eigen onroerend goed
Holdings